We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
- Authors
Riman, Tomas; Dickman, Paul W; Nilsson, Staffan; Correia, Nestor; Nordlinder, Hans; Magnusson, Cecilia M; Weiderpass, Elisabete; Persson, Ingemar R
- Abstract
Estrogen replacement therapy (ERT), which is mainly used to relieve climacteric symptoms, increases a woman's risk for uterine endometrial cancer and epithelial ovarian cancer (EOC). Estrogens are often combined with progestins in hormone replacement therapy (HRT) to reduce the risk of uterine endometrial cancer. Data on the association between HRT including progestins and EOC risk are limited. This nationwide case-control study examined EOC risk in relation to HRT regimens with sequentially added progestins (HRTsp) and continuously added progestins (HRTcp).
- Publication
Journal of the National Cancer Institute, 2002, Vol 94, Issue 7, p497
- ISSN
0027-8874
- Publication type
Journal Article
- DOI
10.1093/jnci/94.7.497